LOS ANGELES, CA--(Marketwired - Apr 1, 2015) -BioSig Technologies ( OTCQB: BSGM), a medical device company developing PURE EP™, a proprietary technology platform designed to improve the clinical outcomes of electrophysiology (EP) procedures, today announced the Company closed a private placement of $4.009 million. Laidlaw & Co (UK) Ltd. served as the sole placement agent...
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.